Claritev PE Ratio 2019-2025 | CTEV

Current and historical p/e ratio for Claritev (CTEV) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Claritev PE ratio as of May 23, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Claritev PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-23 26.56 0.00
2025-03-31 20.63 $-72.72 0.00
2024-12-31 14.78 $-101.54 0.00
2024-09-30 7.64 $-95.05 0.00
2024-06-30 15.52 $-72.40 0.00
2024-03-31 32.44 $-39.20 0.00
2023-12-31 57.60 $-6.00 0.00
2023-09-30 67.20 $-44.80 0.00
2023-06-30 84.40 $-42.00 0.00
2023-03-31 42.40 $-38.80 0.00
2022-12-31 46.00 $-36.00 0.00
2022-09-30 114.40 $6.40 17.88
2022-06-30 219.60 $10.00 21.96
2022-03-31 187.20 $6.40 29.25
2021-12-31 177.20 $6.40 27.69
2021-09-30 225.20 $-6.00 0.00
2021-06-30 380.80 $-22.00 0.00
2021-03-31 222.00 $-19.20 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.437B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.908B 52.36
Hims & Hers Health (HIMS) United States $12.273B 127.51
Tempus AI (TEM) United States $10.830B 0.00
IRhythm Technologies (IRTC) United States $4.555B 0.00
Inspire Medical Systems (INSP) United States $4.224B 66.00
Privia Health (PRVA) United States $2.787B 190.50
Enovis (ENOV) United States $1.803B 10.05
Clover Health Investments (CLOV) United States $1.623B 0.00
Schrodinger (SDGR) United States $1.570B 0.00
Phreesia (PHR) United States $1.431B 0.00
Omnicell (OMCL) United States $1.322B 23.33
Azenta (AZTA) United States $1.236B 57.45
10x Genomics (TXG) United States $1.006B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.537B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.472B 141.00
TruBridge (TBRG) United States $0.357B 791.00
Standard BioTools (LAB) United States $0.350B 0.00
Outset Medical (OM) United States $0.318B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.190B 0.00
EUDA Health Holdings (EUDA) Singapore $0.140B 0.00
Pulmonx (LUNG) United States $0.125B 0.00
KORU Medical Systems (KRMD) United States $0.123B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
CareCloud (CCLD) United States $0.084B 3.21
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00